 | Up a level |
Böhm, Julian; Muenzner, Julienne Kathrin; Caliskan, Aylin; Ndreshkjana, Benardina; Erlenbach-Wünsch, Katharina; Merkel, Susanne; Croner, Roland; Rau, Tilman; Geppert, Carol Immanuel; Hartmann, Arndt; Roehe, Adriana Vial; Schneider-Stock, Regine (2019). Loss of enhancer of zeste homologue 2 (EZH2) at tumor invasion front is correlated with higher aggressiveness in colorectal cancer cells. Journal of cancer research and clinical oncology, 145(9), pp. 2227-2240. 10.1007/s00432-019-02977-1
Rau, Tilman; Atreya, Raja; Aust, Daniela; Baretton, Gustavo; Eck, Matthias; Erlenbach-Wünsch, Katharina; Hartmann, Arndt; Lugli, Alessandro; Stöhr, Robert; Vieth, Michael; Wirsing, Anna M; Zlobec, Inti; Katzenberger, Tiemo (2016). Inflammatory response in serrated precursor lesions of the colon classified according to WHO entities, clinical parameters and phenotype-genotype correlation. The journal of pathology: clinical research, 2(2), pp. 113-124. Wiley 10.1002/cjp2.41
Kraus, Cornelia; Rau, Tilman; Lux, Philipp; Erlenbach-Wünsch, Katharina; Löhr, Sabine; Krumbiegel, Mandy; Thiel, Christian T; Stöhr, Robert; Agaimy, Abbas; Croner, Roland S; Stürzl, Michael; Hohenberger, Werner; Hartmann, Arndt; Reis, André (2015). Comprehensive screening for mutations associated with colorectal cancer in unselected cases reveals penetrant and nonpenetrant mutations. International journal of cancer, 136(6), E559-E568. Wiley-Blackwell 10.1002/ijc.29149
Agaimy, Abbas; Erlenbach-Wünsch, Katharina; Konukiewitz, Björn; Schmitt Kurrer, Anja; Rieker, Ralf J.; Vieth, Michael; Kiesewetter, Franklin; Hartmann, Arndt; Zamboni, Giuseppe; Perren, Aurel; Klöppel, Günter (2013). ISL1 expression is not restricted to pancreatic well-differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrapancreatic origin. Modern pathology, 26(7), pp. 995-1003. Nature Publishing Group 10.1038/modpathol.2013.40
